source
- Experts discuss when to start therapy for pediatric low‑grade glioma, weighing chemo, MEK inhibitors and family factorsIn a recent discussion, pediatric neuro‑oncologists examined how to decide when to begin treatment for low‑grade glioma in children. They highlighted the need to balance chemotherapy and MEK inhibi…
- Dr Randall explains rationale for CSF-1R inhibitor pimicotinib in tenosynovial giant cell tumor trialDr Randall, a professor at UC Davis Comprehensive Cancer Center, discussed the clinical reasoning behind testing the selective CSF-1R inhibitor pimicotinib (ABSK021) for tenosynovial giant cell tum…